Year-end Sale % OFF 
Abstract
SUMMARYSevere allergic reactions (anaphylaxis) are unpredictable, and initial signs of what could be fatal anaphylaxis can be mildAdrenaline (epinephrine) remains the first-line drug of choice for the acute management of anaphylaxis and should be administered earlyThere are no contraindications to intramuscular adrenaline in the treatment of anaphylaxisCorrect positioning of the patient is vital as death can occur within minutes if a patient stands, walks or sits up suddenly. Position the patient correctly first and then promptly administer intramuscular adrenalineUpdated guidelines by the Australasian Society of Clinical Immunology and Allergy now recommend that the 0.15 mg adrenaline injector device may be prescribed for infants and children weighing 7.5–10 kg. The recommendation to use the 0.3 mg adrenaline injector device for those over 20 kg remains unchangedThe adrenaline doses in Australian Prescriber’s anaphylaxis wallchart remain valid
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
